EXEL

Exelixis Stock Analysis

AI Rating

Great
  • Quality9/10
  • Growth↑ 9/10
  • Value↑ 5/10
Exelixis sales and earnings growth
EXEL Growth
Great
  • Revenue Y/Y↑ 6.98%
  • EPS Y/Y↑ 60.00%
  • FCF Y/Y↑ 30.42%
Exelixis gross and profit margin trends
EXEL Profitability
Great
  • Gross margin ↑ 96.40%
  • EPS margin↑ 33.70%
  • ROIC 5Y↑ 22.03%
Exelixis net debt vs free cash flow
EXEL Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Exelixis stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗